Core Scientific investors expected to resist CoreWeave’s merger bid

Core Scientific shareholders oppose CoreWeave's $9 billion acquisition, claiming undervaluation. Investigations launched, with potential shareholder vote expected this fall, emphasizing maximizing value and growth.

Analyst Identifies Two Targets to Take Profit as Shiba Inu Signals Bullish Breakout After Closing Inside Volume Zone

Shiba Inu shows signs of a breakout after reclaiming a key zone, despite recent losses. Analysts remain hopeful for price rallies towards established targets.

Why Did Bitcoin Crash In July? This Explains It

Bitcoin peaked at $123,091 but fell nearly $9,000 due to low demand. Liquidity issues and predictions of further declines contribute to market volatility.

Trading revolution: Perpetual futures take the lead | Opinion

Why Ethereum Retail Investors Remain 'Sidelined'—Even as Institutions Buy Billions

SUP crypto set to debut on Binance Alpha today, what is SUP?

SUP, the native token of Superp, will launch today on Binance Alpha, Bitget, KuCoin, and MEXC, with 1 billion tokens minted and airdrop allocations.

XRP MVRV Flashes Death Cross: More Decline Ahead?

Analyst highlights XRP's MVRV Ratio death cross, indicating possible significant price decline while current trading price is around $3.00.

Discover the Best Blockchain Projects to Invest in for 2025

Ethereum, Solana, and Avalanche show strong bullish momentum, indicating potential as leading blockchain investments by 2025 due to increased market interest and strong technical setups.

CFTC Unveils Initiative for Trading Listed Spot Crypto

CFTC aligns with Trump's crypto policy, launching an initiative for regulated crypto trading and inviting public input to enhance market clarity and access by August 2025.

Investment Giant Paradigm Allegedly Has a Whopping $765 Million Investment in This Altcoin

Paradigm may hold $765.4 million in HYPE tokens, generating approximately $450 million in profit. HYPE is currently trading at $38.05, down 12% in the past week.